Literature DB >> 209229

Establishment of cultured cell lines derived from a human gastric carcinoma.

M Sekiguchi, K Sakakibara, G Fujii.   

Abstract

A human gastric carcinoma cell line, KATO-II, and its subline, KATO-III, have been established in vitro from a pleural effusion of a 55-year-old male patient. Kato-II cells have been maintained using a culture medium containing human cord serum and KATO-III cells have been cultured with a medium containing fetal bovine serum. Both cell lines are morphologically quite similar; they grow in vitro floating free and have cytological features of signet ring cells. Population doubling times for KATO-II and KATO-III were 74 hours and 36 hours, repsectively. The modal chromosomal numbers of these cell lines fell in a tetraploid range. Heterotransplantation of KATO-II and KATO-III cells was successfully done in the cheek pouches of antithymocyte serum-treated hamsters. Microscopical appearance of the resultant tumors was consistent with poorly-differentiated adenocarcinoma comparable to the original tumor.

Entities:  

Mesh:

Year:  1978        PMID: 209229

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  63 in total

1.  Establishment and characteristics of a human signet ring cell gastric carcinoma cell line (SJ-89) under serum-free conditions.

Authors:  Y Dai; H Lin; L Yuan; J Li; Y Li; G Chen; J Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

2.  K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase.

Authors:  M Katoh; Y Hattori; H Sasaki; M Tanaka; K Sugano; Y Yazaki; T Sugimura; M Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Establishment and characterization of a cell line (IGSK-3) secreting human chorionic gonadotropin, adrenocorticotropic hormone and parathyroid hormone-related protein derived from primary poorly differentiated adenocarcinoma of the stomach.

Authors:  Shigeo Yamashita; Naoto Takahashi; Hisashi Hashimoto; Toshiaki Tachibana; Taka Nakahara; Akihiro Ohyama; Katsuhiko Yanaga
Journal:  Hum Cell       Date:  2008-08       Impact factor: 4.174

Review 4.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

5.  Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice.

Authors:  F Gärtner; L David; R Seruca; J C Machado; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

6.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Characterization of a newly established cell line (JR-St) derived from human gastric signet ring cell cancer, producing tumor markers.

Authors:  A Terano; R Nakada; H Mutoh; H Hiraishi; S Ota; S Shiina; T Shimada; Y Itoh; K Kimura; J Shiga
Journal:  Gastroenterol Jpn       Date:  1991-02

8.  Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells.

Authors:  R Pai; F A Wyle; T L Cover; R M Itani; M J Domek; A S Tarnawski
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells.

Authors:  L Matera; E Beltramo; E Martinuzzi; S Buttiglieri
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Secretion of biologically active recombinant human granulocyte-macrophage colony-stimulating factor by transduced gastric cancer cells.

Authors:  Hee-Young Kim; Gil-Soon Park; Ho-Joon Shin; Sun Park; Kyongmin Kim; Hyung-Il Kim
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.